X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Piramal Healthcare with ASTRAZENECA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs ASTRAZENECA PHARMA - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES ASTRAZENECA PHARMA PIRAMAL ENTERPRISES/
ASTRAZENECA PHARMA
 
P/E (TTM) x 36.5 92.6 39.4% View Chart
P/BV x 3.6 13.2 27.6% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 PIRAMAL ENTERPRISES   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-16
ASTRAZENECA PHARMA
Mar-14
PIRAMAL ENTERPRISES/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0651,285 82.9%   
Low Rs805634 127.0%   
Sales per share (Unadj.) Rs383.0189.6 202.0%  
Earnings per share (Unadj.) Rs55.1-0.2 -27,057.0%  
Cash flow per share (Unadj.) Rs74.13.8 1,926.5%  
Dividends per share (Unadj.) Rs17.500-  
Dividend yield (eoy) %1.90-  
Book value per share (Unadj.) Rs719.968.6 1,048.8%  
Shares outstanding (eoy) m172.5625.00 690.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.45.1 48.2%   
Avg P/E ratio x17.0-4,712.7 -0.4%  
P/CF ratio (eoy) x12.6249.6 5.1%  
Price / Book Value ratio x1.314.0 9.3%  
Dividend payout %31.80-   
Avg Mkt Cap Rs m161,34423,988 672.6%   
No. of employees `0003.81.6 242.7%   
Total wages/salary Rs m16,8981,605 1,053.1%   
Avg. sales/employee Rs Th17,472.63,040.2 574.7%   
Avg. wages/employee Rs Th4,466.91,029.2 434.0%   
Avg. net profit/employee Rs Th2,512.8-3.3 -76,964.4%   
INCOME DATA
Net Sales Rs m66,0994,740 1,394.6%  
Other income Rs m2,42592 2,632.6%   
Total revenues Rs m68,5244,832 1,418.2%   
Gross profit Rs m18,723-130 -14,424.2%  
Depreciation Rs m3,274101 3,235.6%   
Interest Rs m9,3880-   
Profit before tax Rs m8,485-139 -6,108.8%   
Minority Interest Rs m30-   
Prior Period Items Rs m1,5930-   
Extraordinary Inc (Exp) Rs m457139 328.8%   
Tax Rs m1,0325 20,273.1%   
Profit after tax Rs m9,506-5 -186,758.3%  
Gross profit margin %28.3-2.7 -1,034.3%  
Effective tax rate %12.2-3.7 -331.9%   
Net profit margin %14.4-0.1 -13,391.8%  
BALANCE SHEET DATA
Current assets Rs m47,4882,726 1,741.8%   
Current liabilities Rs m104,3622,435 4,285.9%   
Net working cap to sales %-86.06.1 -1,399.5%  
Current ratio x0.51.1 40.6%  
Inventory Days Days4174 55.1%  
Debtors Days Days5141 125.5%  
Net fixed assets Rs m26,5321,035 2,562.7%   
Share capital Rs m34550 690.2%   
"Free" reserves Rs m114,024942 12,099.3%   
Net worth Rs m124,2211,716 7,239.0%   
Long term debt Rs m75,8120-   
Total assets Rs m308,3564,156 7,419.5%  
Interest coverage x1.9NM-  
Debt to equity ratio x0.60-  
Sales to assets ratio x0.21.1 18.8%   
Return on assets %6.1-0.1 -5,002.9%  
Return on equity %7.7-0.3 -2,579.9%  
Return on capital %10.00-  
Exports to sales %17.25.7 301.5%   
Imports to sales %6.66.5 102.2%   
Exports (fob) Rs m11,362270 4,204.8%   
Imports (cif) Rs m4,364306 1,424.7%   
Fx inflow Rs m14,435375 3,853.6%   
Fx outflow Rs m5,183470 1,102.3%   
Net fx Rs m9,253-96 -9,683.8%   
CASH FLOW
From Operations Rs m-67,773-8 836,707.4%  
From Investments Rs m-8,768-146 6,017.7%  
From Financial Activity Rs m76,199862 8,837.7%  
Net Cashflow Rs m-342709 -48.3%  

Share Holding

Indian Promoters % 52.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 4.0 0.3 1,333.3%  
FIIs % 26.6 15.7 169.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 9.1 181.3%  
Shareholders   93,274 12,856 725.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   CADILA HEALTHCARE  TTK HEALTHCARE  SHASUN PHARMA  DISHMAN PHARMA  J.B.CHEMICALS  

Compare PIRAMAL ENTERPRISES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Aug 23, 2017 03:36 PM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 5-YR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS